Chen Richard J., McMahon Kathleen, Launico Marjorie V.
Jefferson-Einstein Healthcare Network
Cedars Sinai Marina Del Rey Hospital, Kaiser Permanente
Asthma is a chronic inflammatory airway disease marked by recurrent wheezing, dyspnea, chest pain, and coughing (see . Pathophysiology of Asthma). Recommended treatments for mild-to-moderate asthma exacerbations include β2-agonists and corticosteroids. Patients with status asthmaticus are typically refractory to these standard therapies and may require intravenous medications, continuous nebulizer treatments, and mechanical ventilation. Status asthmaticus is a medical emergency characterized by hypoxemia, hypercarbia, and secondary respiratory failure. The condition may progress to acute respiratory failure, end-organ dysfunction, and death if not promptly recognized and treated aggressively. No single clinical or diagnostic index reliably predicts the outcomes of severe asthma exacerbations. A multipronged approach combining thorough clinical evaluation, judicious diagnostic testing, and rapid symptom management optimizes outcomes in these patients. Embryologically, the respiratory system arises as an outgrowth of the ventral foregut. The trachea develops at the midline and gives rise to the lung buds. The right lung bud divides into 3 main bronchi, while the left lung bud divides into 2. Both main bronchi branch into progressively smaller airways, forming bronchioles, lobules, terminal bronchioles, acini, respiratory bronchioles, alveolar ducts, alveolar sacs, and alveoli. Several terminal bronchioles constitute a pulmonary lobule. Pulmonary and bronchial arteries accompany the airway and lung parenchymal branching. The proximal airways conduct air to the distal lung regions. Cartilaginous tissue supports these airways to maintain patency. Pseudostratified columnar ciliated epithelium lines the larynx, trachea, and bronchi. Neuroendocrine cells in the bronchial mucosa secrete serotonin, calcitonin, and bombesin. Tracheal and bronchial walls also contain submucosal mucous glands. Distal airways have progressively smaller diameters. Cartilage and submucosal mucus glands disappear at the level of the bronchioles. Acini, composed of respiratory bronchioles, are spherical structures distal to the terminal bronchioles and measure approximately 7 mm in diameter. Alveolar ducts arise from the respiratory bronchioles and branch into alveolar sacs. Alveoli develop from respiratory bronchioles, alveolar ducts, or alveolar sacs. The alveolar anatomy is specialized for gas exchange. The blood-air barrier consists of the capillary epithelium, basement membrane, interstitial tissue, alveolar epithelium, and alveolar macrophages. Type I pneumocytes are flat epithelial cells constituting 95% of the alveolar surface. The remaining epithelium comprises Type II pneumocytes, rounded cells that secrete pulmonary surfactant and repair the alveolar epithelium following Type I pneumocyte injury. Pores of Kohn in the alveolar walls connect adjacent alveoli.
哮喘是一种慢性炎症性气道疾病,其特征为反复发作的喘息、呼吸困难、胸痛和咳嗽(见哮喘病理学)。针对轻至中度症状急性发作的推荐治疗方法包括β受体激动剂和类固醇。然而,当患者对标准哮喘治疗无反应时,就会出现哮喘持续状态。哮喘持续状态是一种医疗紧急情况,是哮喘加重的一种极端形式,其特征为低氧血症、高碳酸血症和继发性呼吸衰竭。所有支气管哮喘患者都有发生这种情况的风险,病情可能进展,对标准治疗措施反应不佳。如果未得到正确识别和处理,哮喘持续状态可导致急性通气衰竭甚至死亡。尽管药物治疗取得了进展,但哮喘持续状态仍然是急诊科就诊的最常见原因之一。目前尚无单一的临床或诊断指标可预测这种情况的临床结果。采用多管齐下的方法,结合临床评估、适当的诊断测试和快速缓解症状,可改善此类患者的治疗结果。在胚胎学上,呼吸系统是腹侧前肠的衍生物。气管在中线处发育并产生肺芽。右肺芽分为3个主要支气管,而左肺芽分为2个。右主支气管比左主支气管更垂直,因此更容易发生异物吸入。左右主支气管逐渐分支形成越来越小的气道,形成细支气管、小叶、终末细支气管、腺泡、呼吸性细支气管、肺泡管、肺泡囊和肺泡。肺动脉和支气管动脉跟随气道和肺实质分支。几个终末细支气管形成一个肺小叶。假复层柱状纤毛上皮覆盖喉、气管和支气管表面。软骨组织也支撑这些气道。神经内分泌细胞大量存在于支气管黏膜中,分泌血清素、降钙素和蛙皮素。气管和支气管壁中也有黏膜下黏液腺。软骨和黏膜下黏液腺在细支气管水平消失。终末细支气管直径小于2毫米。腺泡是终末细支气管远端的球形结构,直径为7毫米,由呼吸性细支气管组成。肺泡管由呼吸性细支气管发出并分支形成肺泡囊。肺泡可由呼吸性细支气管、肺泡管和肺泡囊产生。肺泡是肺的气体交换单位。气血屏障由毛细血管上皮、基底膜、间质组织、肺泡上皮和肺泡巨噬细胞组成。I型肺泡细胞是扁平细胞,占肺泡上皮的95%。II型肺泡细胞是圆形细胞,在肺泡腔内分布较稀疏。II型肺泡细胞分泌肺表面活性物质,并在I型肺泡细胞受损时修复肺泡上皮。肺泡壁上的孔氏孔是微生物和渗出液在肺泡之间扩散的潜在部位。